Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The concept of a combination therapy involving acyclovir, valacyclovir, and a topical corticosteroid for treating herpes simplex virus infections, particularly cold sores (herpes labialis). While antiviral medications (acyclovir or valacyclovir) are used with topical corticosteroids, there is no single commercial product that contains all three active ingredients together. The combination approach aims to target viral replication through antivirals and reduce inflammation through corticosteroids. Studies have examined combinations like acyclovir with hydrocortisone (e.g., Xerese) and valacyclovir with topical corticosteroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acyclovir + valacyclovir + topical corticosteroid.